RRP ISA Survey Results
HOME
LEARN
Changes to RRP ISA (June 2010)
Requests for Exceptions
Considerations for Newly Diagnosed Patients
FAQ
HPV Prevention and Treatment
Cervical Obsessions
Dropping the Ball
Educational Sweet Spot
Epidemiology
HPV and Oral Sex
HPV Disease
HPV Prevention
Kids and RRP (JOORP)
Kid-Specific Resources
Risk Factors for JOORP
Treatment-Related Issues
Managing HPV-16
by Bettie Steinberg, PhD
Novel Therapies (Artemisinin/Gardasil)
Artemisinin/Gardasil Ethical Issues
Artemisinin Patient Reports
Artemisinin Safety and Pharmacokinetics
Artemisinin Usage Guidelines (Part I)
Artemisinin Usage Guidelines (Part II)
Resistance to ART (cautionary note)
RRP ISA/RRPF Joint Letter on Artemisinin
Rumors of Toxicity, Ridicule and Racism
The Question of Medical Supervision
Wikipedia on Artemisinin
Pulmonary RRP
Resources
RRP Focus Sessions
2007 (Washington DC)
2005 (Los Angeles)
2005 (Vanvouver BC)
2004 (New York City)
2002 (San Diego)
Treatment Strategies
HOW YOU CAN HELP
Advocacy
Empowering Patients
Kathy Story (2005)
Kristina's Story (1999)
Sanford Foundation Initiative
Sherry's Story (2008)
Corporate Partners and Affiliates
Participate
Volunteer
Why Volunteer?
PROFESSIONALS & RESEARCHERS
Cidofovir (by RRP Taskforce, Cautionary)
Grant -Making
In the News
News About RRP
News About HPV
News About RRP ISA
Informed Consent on MMR, etc. (by Bettie Steinberg, PhD)
Library
A Bronchoscopic Picture Atlas
Data Trends Reports
HPV Vaccines
Popular Press
Rare Disease Illuminates Cancer's Early Stages
Research Articles (RRP)
RRP Taskforce
RRP ISA/RRPF Joint Letter on Artemisinin
RRP Research & Treatment Protocols
Celebrex
Dr. Ian Frazer (RRP Therapeutic)
Pulsed-Dye Laser and DIM in Children
Pulsed-Dye Laser for Children
COMMUNICATE
RRP Forum
RRP ISA Newsletter
Newsletter 2/7/08
Newsletter 3/4/08
Newsletter 4/29/08
Newsletter 6/26/08
Newsletter: 9-27-08
Newsletter: 11-19-08
Newsletter: 4-22-09
RRP Shout Blog
ABOUT US
Accomplishments
Mission and Goals
Brochure
Contact Us
Organizational Structure
Board and Staff
Scientific Advisory Panel
Learn
Changes to RRP ISA (June 2010)
Considerations for Newly Diagnosed Patients
FAQ
HPV Prevention and Treatment
Kids and RRP (JOORP)
Managing HPV-16
Novel Therapies (Artemisinin/Gardasil)
Pulmonary RRP
Resources
RRP Focus Sessions
Treatment Strategies
(Important Disclaimer)
Order copies
Learn
Home
»
Learn
»
Novel Therapies (Artemisinin/Gardasil)
»
Artemisinin Usage Guidelines (Part I)
Artemisinin Usage Guidelines (Part I)
As of June 22, 2010, this page is deactivated. It has, of course, been saved, but it is now hidden. Please
click here
for explanation and back story.
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
OpenCube - The Internets #1 CSS Menu, Drop Down Menu, Flyout Menu, and Pop Up menu Developer